Ackman: Valeant underinvested in communications

Pershing Square Capital's Bill Ackman said Valeant Pharmaceuticals made a mistake by underinvesting in communications.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.